BLPH Market Cap History
Below is a table of the BLPH market cap history going back to 2/13/2015:

Date BLPH Market Cap
2/13/2015106.79M
3/25/2015130.22M
5/11/2015110.08M
8/10/201539.77M
11/9/201541.92M
3/10/201640.57M
5/5/201624.39M
8/5/201623.65M
11/7/201614.80M
3/2/201742.61M
5/10/201752.12M
8/3/201745.45M
11/1/201776.15M
3/10/2018106.13M
5/9/2018125.86M
7/31/2018144.50M
11/6/201852.52M
3/12/201946.17M
5/8/201944.79M
8/7/201945.62M
8/5/201913.56M
11/5/201931.63M
2/10/202018.35M
4/3/202063.10M
5/8/2020104.31M
8/3/2020120.15M
11/4/202083.20M
3/8/202158.37M
5/7/202138.31M
8/3/202139.36M
11/12/202129.85M

Also see: BLPH Shares Outstanding History
and BLPH YTD Return
BLPH Historical Market Cap:
-17.21% CAGR
BLPH Historical Market Cap: +-17.21% CAGR

Mouse over chart for data details
2/13/2015 ...11/12/2021
Bellerophon Therapeutics is a clinical-stage therapeutics company focused on developing products for the treatment of cardiopulmonary diseases. Co.'s focus is on the development of its nitric oxide therapy for patients with or at risk of pulmonary hypertension (PH) using its proprietary pulsatile nitric oxide delivery platform, INOpulse. INOpulse program is an extension of the technology used in hospitals to deliver continuous-flow inhaled nitric oxide. Co. is developing INOpulse for the treatment of fibrotic interstitial lung disease at risk of PH, PH associated with chronic obstructive pulmonary disease and PH associated with Sarcoidosis. We show 31 historical shares outstanding datapoints in our BLPH shares outstanding history coverage, used to compute BLPH market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BLPH market cap history over the course of time is important for investors interested in comparing BLPH's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BLPH versus a peer is one thing; comparing BLPH market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BLPH can fluctuate over the course of history. With this page we aim to empower investors researching BLPH by allowing them to research the BLPH market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree BLPH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Bellerophon Therapeutics (BLPH) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

BLRX Market Cap History
BLUE Market Cap History
BMEA Market Cap History
BMRA Market Cap History
BMRN Market Cap History
BMY Market Cap History
BNGO Market Cap History
BNTC Market Cap History
BOLD Market Cap History
BOLT Market Cap History
More Healthcare companies »

 

BLPH Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.